Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04778163
Other study ID # CDEVILLE
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date September 19, 2019
Est. completion date October 31, 2022

Study information

Verified date October 2022
Source University Hospital, Geneva
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Clinical study in psychiatry in young adult patients between 18 and 25 years old. The aim of the study is to evaluate the therapeutic impact of the clinical use of humor through 6 group sessions (group of 5 to 10 patients), at the rate of one hour session per week for 6 weeks. The investigators will form 2 groups of 5 to 10 patients matched in terms of gender, education level and score on a scale measuring their sense of humor. The participants will be asked to complete a series of tests measuring their ability to use humor, psychiatric symptoms and well-being. Group 1 (test group) will participate in the humor-based sessions, while Group 2 (control group) will receive regular treatment for 6 weeks (waiting list: patients in Group 2 will attend humor-based sessions once Group 1 has completed their 6 weeks). At the end of the 6-week sessions, both groups will receive the same series of pre-session tests to see whether or not there has been improvement in their overall functioning, psychiatric symptomatology and appreciation/use of humor. At the end of the 2x 6-week sessions, group 2 will again receive this series of pre-session tests to see whether or not their overall functioning, psychiatric symptomatology and appreciation/use of humour has improved. Objective(s)/Aim: To evaluate the resilience of young adult psychiatric patients and their ability to cope with stress through the use of humor in a set of 6 modules on the use of humor. To evaluate the symptoms. Outcome/Endpoints : Using scales, measure this evolution.


Description:

Project design and procedures : The investigators will form 2 groups of 5 to 10 patients matched on their score on the sense of humor scale, their gender and their level of education. The participants will be asked to complete a series of tests measuring their ability to use humor, clinical variables and general functioning. Group 1 - experimental - will participate in a "humor group" with a one-hour group session per week for 6 weeks. Group 2 - the control group - will follow a usual treatment regimen for 6 weeks. At the end of the "Humor Group" of group 1, the 2 groups of patients will undergo a second series of tests identical to those of the pregroup. The paired patients should be randomly assigned. The control group will do the "Humor Group" after 6 weeks.


Recruitment information / eligibility

Status Completed
Enrollment 34
Est. completion date October 31, 2022
Est. primary completion date June 30, 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years to 25 Years
Eligibility Inclusion Criteria: - Young adult patients of a psychiatric's unit (young people from 18 to 25 years old with beginner psychic disorders) who are French-speaking and able to give their informed consent. Exclusion Criteria: - Those who do not meet the above criteria.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Clinical use of humor
Clinical study in psychiatry in young adult patients between 18 and 25 years old. The aim of the study is to evaluate the therapeutic impact of the clinical use of humor through 6 group sessions (group of 5 to 10 patients), at the rate of one hour session per week for 6 weeks. The investigators will form 2 groups of 5 to 10 patients matched in terms of gender, education level and score on a scale measuring their sense of humor. The participants will be asked to complete a series of tests measuring their ability to use humor, psychiatric symptoms and well-being.

Locations

Country Name City State
Switzerland Programme JADE Geneva

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Geneva

Country where clinical trial is conducted

Switzerland, 

References & Publications (16)

Bozikas VP, Kosmidis MH, Giannakou M, Anezoulaki D, Petrikis P, Fokas K, Karavatos A. Humor appreciation deficit in schizophrenia: the relevance of basic neurocognitive functioning. J Nerv Ment Dis. 2007 Apr;195(4):325-31. — View Citation

Cai C, Yu L, Rong L, Zhong H. Effectiveness of humor intervention for patients with schizophrenia: a randomized controlled trial. J Psychiatr Res. 2014 Dec;59:174-8. doi: 10.1016/j.jpsychires.2014.09.010. Epub 2014 Sep 19. — View Citation

Compas BE, Connor-Smith JK, Saltzman H, Thomsen AH, Wadsworth ME. Coping with stress during childhood and adolescence: problems, progress, and potential in theory and research. Psychol Bull. 2001 Jan;127(1):87-127. Review. — View Citation

Corcoran R, Cahill C, Frith CD. The appreciation of visual jokes in people with schizophrenia: a study of 'mentalizing' ability. Schizophr Res. 1997 Apr 11;24(3):319-27. — View Citation

Corrigan PW, Powell KJ, Fokuo JK, Kosyluk KA. Does humor influence the stigma of mental illnesses? J Nerv Ment Dis. 2014 May;202(5):397-401. doi: 10.1097/NMD.0000000000000138. — View Citation

Derouesné C. [Neuropsychology of humor: an introduction Part 1. Psychological data]. Geriatr Psychol Neuropsychiatr Vieil. 2016 Mar;14(1):95-103. doi: 10.1684/pnv.2016.0583. Review. French. — View Citation

Etienne E, Braha S, Januel D. [Humour and the theory of mind in schizophrenia: a review of the literature]. Encephale. 2012 Apr;38(2):164-9. doi: 10.1016/j.encep.2011.03.008. Epub 2011 Jul 5. Review. French. — View Citation

Falkenberg I, Buchkremer G, Bartels M, Wild B. Implementation of a manual-based training of humor abilities in patients with depression: a pilot study. Psychiatry Res. 2011 Apr 30;186(2-3):454-7. doi: 10.1016/j.psychres.2010.10.009. Epub 2010 Nov 11. — View Citation

Franzini LR. Humor in therapy: the case for training therapists in its uses and risks. J Gen Psychol. 2001 Apr;128(2):170-93. Review. — View Citation

McGhee, P. (1994). How to develop your sense of humor. Dubuque: Kendall Hunt.

Rengade, C.E. (2014). L'humour en thérapie cognitive et comportementale. J thér comport cogn, 24(1), 1-4.

Rudnick A, Kohn PM, Edwards KR, Podnar D, Caird S, Martin R. Humour-related interventions for people with mental illness: a randomized controlled pilot study. Community Ment Health J. 2014 Aug;50(6):737-42. doi: 10.1007/s10597-013-9685-4. Epub 2013 Dec 12 — View Citation

Salameh, W.A. (1983). Humor in psychotherapy: past outlooks, present status, and future frontiers. In: McGhee, P.E., Goldstein, J.H., editors. Handbook of humor research. Volume II Applied studies. New York: Springer, 61-88.

Valentine L, Gabbard GO. Can the use of humor in psychotherapy be taught? Acad Psychiatry. 2014 Feb;38(1):75-81. doi: 10.1007/s40596-013-0018-2. Review. — View Citation

Ventura J, Nuechterlein KH, Subotnik KL, Gutkind D, Gilbert EA. Symptom dimensions in recent-onset schizophrenia and mania: a principal components analysis of the 24-item Brief Psychiatric Rating Scale. Psychiatry Res. 2000 Dec 27;97(2-3):129-35. — View Citation

Ventura, J., Green, M.F., Shaner, A., Liberman, R.P. (1993). Training and quality assurance with the Brief Psychiatric Rating Scale: "The drift busters". International Journal of Methods in Psychiatry Research, 3, 221-224.

* Note: There are 16 references in allClick here to view all references

Outcome

Type Measure Description Time frame Safety issue
Primary Primary outcome is sense of humor using scale : Sense of Humor Scale (from 36 to 144 : higher scores mean a better outcome). To evaluate whether or not their appreciation/use of humor has improved. About three years
Secondary Coping evolution using scale : Coping Humor Scale (from (-14) to (+14) : higher scores mean a better outcome). To evaluate whether or not the coping evolution has improved. About three years
Secondary Psychiatric symptoms evolution using scale : Brief Psychiatric Rating Scale (from 24 to 168 : higher scores mean a worse outcome). To evaluate whether or not the overall psychiatric symptomatology has improved. About three years
Secondary Global functioning using scales : Global Assessment Functioning (from 1 to 100 : higher scores mean a better outcome). To evaluate whether or not the overall functioning has improved. About three years
Secondary Clinical global impression using scale : Clinical Global Impression (from 1 to 7 : higher scores mean a worse outcome). To evaluate whether or not the overall global clinical impression has improved. About three years
See also
  Status Clinical Trial Phase
Completed NCT03409991 - Testing the Efficacy of Opening Doors: A Career Guidance Intervention for Individuals With Psychiatric Disabilities N/A
Not yet recruiting NCT05316948 - Mental Health and Sexuality in Adolescents and Young Adults
Not yet recruiting NCT06304363 - Braining - Evaluation of Acute Effects of Physical Exercise N/A
Recruiting NCT04096625 - Enhancement of a Psychotherapeutic Intervention Through Transcranial Direct Current Stimulation (tDCS) N/A
Not yet recruiting NCT05930353 - Psychometric Validation of a French-language Version of the PERMA-Profiler: Tools for Assessing Multidimensional Subjective Well-being
Terminated NCT06012981 - Psychological Treatment in Psychiatric Inpatient Care N/A
Completed NCT04099173 - A Brief Mindfulness-Based Intervention for Suicidal Ideation N/A
Completed NCT01866956 - Computerized Screening for Comorbidity in Adolescents With Substance or Psychiatric Disorders
Recruiting NCT04249960 - Sustain and Reinforce the Transition From Child to Adult Mental Health Care in Switzerland : A Monocentric Nested Cohort Randomized Controlled Trial: The SORT Study. N/A
Recruiting NCT05962424 - HNC: Human Neural Circuits Electrophysiology During Cognition Phase 1
Recruiting NCT06092866 - Digital Versus Telephone Symptom Assessment and Triage in Primary Care N/A
Recruiting NCT03678194 - Treating Depression on a Day-to-day Basis: Development of a Tool for Physicians Based on a Smartphone Application N/A
Completed NCT03748355 - Using Pharmacogenetics to Identify Patients With Polypharmacy at Risk of Medication Adverse Effects N/A
Completed NCT05473962 - Mid-Term Follow-up Assessment After Exposure to Natural Disaster
Recruiting NCT05577585 - Ketamine and Stress in OCD N/A
Completed NCT05124158 - COVID-19 Severity and Psychiatric Morbidity
Recruiting NCT05560581 - Digital Self-efficacy Training to Bridge Waiting Times for Psychotherapy N/A
Completed NCT04618250 - Improving Physical Health in Patients With Psychiatric Disorders in General Practice (SOFIA) N/A
Not yet recruiting NCT06014164 - Qualitative Study About Psychedelics Using in Psychiatric Disorders
Active, not recruiting NCT05219357 - Ayurveda Based Intervention for Patients in Acute Psychiatric Crisis Situations N/A